U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C23H32F3N5O4
Molecular Weight 499.5265
Optical Activity UNSPECIFIED
Defined Stereocenters 6 / 6
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Nirmatrelvir

SMILES

[H][C@]12CN([C@H](C(=O)N[C@@H](C[C@@H]3CCNC3=O)C#N)[C@@]1([H])C2(C)C)C(=O)[C@@H](NC(=O)C(F)(F)F)C(C)(C)C

InChI

InChIKey=LIENCHBZNNMNKG-OJFNHCPVSA-N
InChI=1S/C23H32F3N5O4/c1-21(2,3)16(30-20(35)23(24,25)26)19(34)31-10-13-14(22(13,4)5)15(31)18(33)29-12(9-27)8-11-6-7-28-17(11)32/h11-16H,6-8,10H2,1-5H3,(H,28,32)(H,29,33)(H,30,35)/t11-,12-,13-,14-,15-,16+/m0/s1

HIDE SMILES / InChI

Molecular Formula C23H32F3N5O4
Molecular Weight 499.5265
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 6 / 6
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 17:16:02 GMT 2023
Edited
by admin
on Sat Dec 16 17:16:02 GMT 2023
Record UNII
7R9A5P7H32
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Nirmatrelvir
USAN  
Official Name English
PAXLOVID COMPONENT NIRMATRELVIR
Brand Name English
nirmatrelvir [INN]
Common Name English
3-Azabicyclo[3.1.0]hexane-2-carboxamide, N-[(1S)-1-cyano-2-[(3S)-2-oxo-3-pyrrolidinyl]ethyl]-3-[(2S)-3,3-dimethyl-1-oxo-2-[(2,2,2-trifluoroacetyl)amino]butyl]-6,6-dimethyl-, (1R,2S,5S)-
Systematic Name English
PF07321332
Code English
NIRMATRELVIR [JAN]
Common Name English
(1R,2S,5S)-N-{(1S)-1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl}-3-[(2S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide
Systematic Name English
PF-07321332
Code English
NIRMATRELVIR COMPONENT OF PAXLOVID
Brand Name English
Nirmatrelvir [WHO-DD]
Common Name English
NIRMATRELVIR [USAN]
Common Name English
Code System Code Type Description
CAS
2628280-40-8
Created by admin on Sat Dec 16 17:16:03 GMT 2023 , Edited by admin on Sat Dec 16 17:16:03 GMT 2023
PRIMARY
CHEBI
170007
Created by admin on Sat Dec 16 17:16:03 GMT 2023 , Edited by admin on Sat Dec 16 17:16:03 GMT 2023
PRIMARY
INN
12161
Created by admin on Sat Dec 16 17:16:03 GMT 2023 , Edited by admin on Sat Dec 16 17:16:03 GMT 2023
PRIMARY
SMS_ID
300000031355
Created by admin on Sat Dec 16 17:16:03 GMT 2023 , Edited by admin on Sat Dec 16 17:16:03 GMT 2023
PRIMARY
RXCUI
2587892
Created by admin on Sat Dec 16 17:16:03 GMT 2023 , Edited by admin on Sat Dec 16 17:16:03 GMT 2023
PRIMARY
DAILYMED
7R9A5P7H32
Created by admin on Sat Dec 16 17:16:03 GMT 2023 , Edited by admin on Sat Dec 16 17:16:03 GMT 2023
PRIMARY
PUBCHEM
155903259
Created by admin on Sat Dec 16 17:16:03 GMT 2023 , Edited by admin on Sat Dec 16 17:16:03 GMT 2023
PRIMARY
EPA CompTox
DTXSID501336829
Created by admin on Sat Dec 16 17:16:03 GMT 2023 , Edited by admin on Sat Dec 16 17:16:03 GMT 2023
PRIMARY
USAN
JK-210
Created by admin on Sat Dec 16 17:16:03 GMT 2023 , Edited by admin on Sat Dec 16 17:16:03 GMT 2023
PRIMARY
NCI_THESAURUS
C182119
Created by admin on Sat Dec 16 17:16:03 GMT 2023 , Edited by admin on Sat Dec 16 17:16:03 GMT 2023
PRIMARY
WIKIPEDIA
Nirmatrelvir
Created by admin on Sat Dec 16 17:16:03 GMT 2023 , Edited by admin on Sat Dec 16 17:16:03 GMT 2023
PRIMARY
FDA UNII
7R9A5P7H32
Created by admin on Sat Dec 16 17:16:03 GMT 2023 , Edited by admin on Sat Dec 16 17:16:03 GMT 2023
PRIMARY
Related Record Type Details
TARGET ORGANISM->INHIBITOR
human adenocarcinoma-derived alveolar basal epithelial cells
EC90
BINDER->LIGAND
LABELED -> NON-LABELED
TRANSPORTER -> INHIBITOR
IC50
SALT/SOLVATE -> PARENT
TRANSPORTER -> INHIBITOR
TARGET -> INHIBITOR
Protease activity inhibited via a reversible covalent mechanism involving reaction of the cyano group with the catalytic Cys145 residue
Ki
METABOLIC ENZYME -> SUBSTRATE
TARGET ORGANISM->INHIBITOR
Differentiated normal human bronchial epithelial (dNHBE) cells
EC90
EXCRETED UNCHANGED
URINE
EXCRETED UNCHANGED
FECAL
EXCRETED UNCHANGED
Total from feces and urine.
FECAL; URINE
METABOLIC ENZYME -> INHIBITOR
TIME-DEPENDENT INHIBITION
SOLVATE->ANHYDROUS
TARGET -> INHIBITOR
Related Record Type Details
METABOLITE -> PARENT
METABOLITE LESS ACTIVE -> PARENT
Epithelial Vero E6 cells;EC50 = 694 EC50 Nirmatrelvir = 74.5
MAJOR
EC50
METABOLITE -> PARENT
METABOLITE -> PARENT
METABOLITE -> PARENT
Only detected in feces
MINOR
FECAL
METABOLITE -> PARENT
METABOLITE INACTIVE -> PARENT
URINE
Related Record Type Details
ACTIVE MOIETY